While Merck's COVID pill molnupiravir is poised for authorization, efficacy could hamper use
30 November 2021 - 05:48AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2023 to Mar 2024